+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Trends in survival for both histologic types of esophageal cancer in Switzerland



Trends in survival for both histologic types of esophageal cancer in Switzerland



International Journal of Cancer 108(4): 638-639



Angiogenesis is thought to play a major role in the development of Kaposi's sarcoma (KS), considered by many to be a hyperplastic disorder caused in part by local production of inflammatory cytokines. The antiangiogenic effects of protease inhibitors, in particular ritonavir, have been suggested in laboratory work to lead to regression of KS, and recent data have shown the importance of ritonavir as a model of pharmaceutical development. As our clinical cohort data has shown that non-nucleoside reverse transcriptase inhibitor-based regimens are not inferior to protease inhibitor-based therapy in the prevention of KS, we investigated the specific contribution of ritonavir to chemoprevention of this AIDS-defining illness. In a logistic regression analysis, we found that ritonavir-based therapy confers no advantages compared to other regimens in the prevention of KS. This is consistent with data suggesting that regression of KS is mediated by an overall improvement in immune function and not by the effects of specific antiretrovirals.

(PDF emailed within 0-6 h: $19.90)

Accession: 035985560

Download citation: RISBibTeXText

PMID: 14696135

DOI: 10.1002/ijc.11611


Related references

Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. International Journal of Cancer 105(1): 98-100, 2003

Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. International Journal of Cancer 99(6): 860-868, 2002

Secular trends in histologic types of lung cancer. Journal of the National Cancer Institute 77(1): 53-56, 1986

Trends in cancer survival in Vaud, Switzerland. European Journal of Cancer 28a(8-9): 1490-1495, 1992

Trends of lung cancer incidence by histologic types in Japan. Japanese Journal of Cancer Research 90(1): Inside Front Cover-Inside Front Cover, 1999

Synchronous or Metachronous Occurrence of Lesions of Different Histologic Types in Patients With Esophageal Cancer. Clinical Gastroenterology and Hepatology 15(5): 780-781, 2016

Survival of lung cancer patients of different histologic types. Journal of the Formosan Medical Association 89(5): 407-412, 1990

Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases. Annals of Diagnostic Pathology 11(2): 89-96, 2007

Improved survival in both histologic types of oesophageal cancer in Sweden. International Journal of Cancer 99(5): 751-754, 2002

Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993. Annals of Oncology 11(8): 957-963, 2000

Childhood cancer survival in Switzerland (1976-2013): Time-trends and predictors. International Journal of Cancer 140(1): 62-74, 2016

Time trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983-2000. Lung Cancer 45(2): 143-152, 2004

Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study. Lung Cancer 10(5-6): 287-296, 1994

StatBite: Breast cancer: 5-year survival rates in U.S. for selected histologic types by stage. Journal of the National Cancer Institute 101(19): 1303-1303, 2009

The use of a multiple imputation method to investigate the trends in Histologic types of lung cancer in Songkhla province, Thailand, 1989-2013. Bmc Cancer 16: 389, 2017